UK markets closed

Innovent Biologics, Inc. (1801.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
38.200-1.950 (-4.86%)
At close: 04:08PM HKT
Currency in HKD

Valuation measures4

Market cap (intra-day) 65.12B
Enterprise value 57.98B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)9.18
Price/book (mrq)4.73
Enterprise value/revenue 8.50
Enterprise value/EBITDA -19.71

Trading information

Stock price history

Beta (5Y monthly) 0.17
52-week change 3-0.12%
S&P500 52-week change 328.04%
52-week high 349.800
52-week low 327.300
50-day moving average 338.509
200-day moving average 339.117

Share statistics

Avg vol (3-month) 38.56M
Avg vol (10-day) 36.58M
Shares outstanding 51.62B
Implied shares outstanding 61.62B
Float 81.41B
% held by insiders 17.07%
% held by institutions 152.55%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -16.56%
Operating margin (ttm)-24.11%

Management effectiveness

Return on assets (ttm)-5.11%
Return on equity (ttm)-8.84%

Income statement

Revenue (ttm)6.21B
Revenue per share (ttm)3.98
Quarterly revenue growth (yoy)51.30%
Gross profit (ttm)N/A
EBITDA -1.29B
Net income avi to common (ttm)-1.03B
Diluted EPS (ttm)-0.730
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)10.97B
Total cash per share (mrq)6.76
Total debt (mrq)3.62B
Total debt/equity (mrq)28.90%
Current ratio (mrq)3.00
Book value per share (mrq)7.72

Cash flow statement

Operating cash flow (ttm)147.81M
Levered free cash flow (ttm)-907.54M